Enhancing Use of Hydroxyurea In Sickle Cell Disease Using Patient Navigators
NCT02197845 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 353
Last updated 2023-06-02
Summary
Multi-phase, patient navigator-based program in the Richmond and Tidewater regions of Virginia to demonstrate:
1. the feasibility of using patient navigators to improve the percentage of children and adult (age 15 and older) patients with sickle cell disease (SCD) in SCD specialty care
2. the efficacy of using patient navigators to improve hydroxyurea (HU) (re-)initiation and adherence among adult patients with SCD eligible for HU
(Patient navigators may also be known as public health workers.)
Conditions
Interventions
- BEHAVIORAL
-
Patient Navigator
A specially trained (SCD knowledgable) Patient Navigator will act as a liaison who assists participants in increasing adherence to HU through disease education, addressing barriers to care and improving adherence to HU. PN utilize various techniques geared toward the individual patients needs. Interventions utilized by a PN include improving disease management skills, educational materials about disease, HU adherence, motivational interviewing, care coordination and social support.
- BEHAVIORAL
-
Recruitment into Specialty Care
A specially trained (SCD knowledgeable) Patient Navigator will act as a liaison to participants in increasing adherence to Hydroxyurea. Interventions utilized by a PN include teaching disease management skills, addressing barriers to care, disease education, HU management, motivational interviewing, care coordination and social support.
Sponsors & Collaborators
-
Eastern Virginia Medical School
collaborator OTHER -
Children's Hospital of The King's Daughters
collaborator OTHER -
Virginia Department of Health
collaborator OTHER_GOV -
James Madison University
collaborator OTHER -
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Virginia Commonwealth University
lead OTHER
Principal Investigators
-
Wally R Smith, MD · Virginia Commonwealth University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 15 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-10-31
- Primary Completion
- 2018-07-07
- Completion
- 2018-12-31
Countries
- United States
Study Locations
More Related Trials
-
Patient Centered Comprehensive Medication Adherence Management System in Patients With Sickle Cell Disease
NCT02371720 ·Status: COMPLETED ·Phase: NA
-
Hydroxyurea to Prevent Brain Injury in Sickle Cell Disease
NCT01389024 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of a Decision Aid for Hydroxyurea in Sickle Cell Disease
NCT03577691 ·Status: TERMINATED ·Phase: NA
-
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
NCT00305175 ·Status: COMPLETED
-
A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study
NCT00895154 ·Status: COMPLETED ·Phase: NA
-
Use of Hydroxyurea and Magnesium Pidolate for Treatment of Sickle Cell Disease
NCT00143572 ·Status: COMPLETED ·Phase: PHASE1
-
Home-based Assessment of PRO Measures in SCD Using A Smartphone App Platform: A Feasibility Study
NCT04678037 ·Status: COMPLETED ·Phase: NA
-
Adherence to Hydroxyurea in Children With Sickle Cell Anemia
NCT00672789 ·Status: COMPLETED ·Phase: NA
-
Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD
NCT04388241 ·Status: COMPLETED ·Phase: NA
-
Hydroxyurea to Prevent Stroke in Children With Sickle Cell Anemia and Elevated TCD Flow Velocity
NCT00402480 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetics (PK) of Liquid Hydroxyurea in Pediatric Patients With Sickle Cell Anemia
NCT01506544 ·Status: COMPLETED ·Phase: PHASE1
-
Parent Educational Program for Children With Sickle Cell Disease
NCT00860782 ·Status: COMPLETED ·Phase: NA
-
Therapeutic Response Evaluation and Adherence Trial (TREAT)
NCT02286154 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
A Study to Learn About Sickle Cell Disease In Adult Patients
NCT05407805 ·Status: COMPLETED
-
A Socio-ecological Approach for Improving Self-management in Adolescents With SCD
NCT06290401 ·Status: RECRUITING ·Phase: NA
-
Telemedicine for Children With Sickle Cell Disease
NCT05087303 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension
NCT00350844 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Study of Hydroxyurea to Treat Sickle Cell Disease
NCT02868138 ·Status: COMPLETED
-
Assessing Physical Function in Sickle Cell Patients Taking Voxelotor
NCT06023199 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Hydroxyurea Management in Kids: Intensive Versus Stable Dosage Strategies
NCT03020615 ·Status: COMPLETED ·Phase: PHASE2
-
Inflammatory Response to Hydroxyurea Therapy in Sickle Cell Disease
NCT00784082 ·Status: COMPLETED
-
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
NCT06919224 ·Status: RECRUITING ·Phase: NA
-
Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia
NCT00270478 ·Status: COMPLETED ·Phase: PHASE1
-
Hydroxyurea in Young Children With Sickle Cell Anemia
NCT00519701 ·Status: COMPLETED ·Phase: NA
-
A 3-year, Prospective, Non-interventional, Multicenter Registry in Sickle Cell Disease (SCD) Patients
NCT01220115 ·Status: COMPLETED